Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilage.
about
Acquiring chondrocyte phenotype from human mesenchymal stem cells under inflammatory conditionsPotential benefits and limitations of utilizing chondroprogenitors in cell-based cartilage therapyMaintenance of "stem cell" features of cartilage cell sub-populations during in vitro propagation.Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo.Toward regeneration of articular cartilage.Engineering superficial zone chondrocytes from mesenchymal stem cells.Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling.IL-17 inhibits chondrogenic differentiation of human mesenchymal stem cellsRunx1 Activities in Superficial Zone Chondrocytes, Osteoarthritic Chondrocyte Clones and Response to Mechanical Loading.Resident mesenchymal progenitors of articular cartilage.Type II collagen and glycosaminoglycan expression induction in primary human chondrocyte by TGF-β1.Changes in Chondrogenic Progenitor Populations Associated with Aging and Osteoarthritis.The distribution pattern of critically short telomeres in human osteoarthritic knees.Comparison between normal and loose fragment chondrocytes in proliferation and redifferentiation potential.Altered function in cartilage derived mesenchymal stem cell leads to OA-related cartilage erosionHuman Cartilage-Derived Progenitor Cells From Committed Chondrocytes for Efficient Cartilage Repair and Regeneration.Chondrogenic Potency Analyses of Donor-Matched Chondrocytes and Mesenchymal Stem Cells Derived from Bone Marrow, Infrapatellar Fat Pad, and Subcutaneous Fat.Toll-like receptors in human chondrocytes and osteoarthritic cartilage.Adipose, Bone Marrow and Synovial Joint-Derived Mesenchymal Stem Cells for Cartilage Repair.Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment.Surface markers for chondrogenic determination: a highlight of synovium-derived stem cells.MicroRNAs are potential prognostic and therapeutic targets in diabetic osteoarthritis.Origin and function of cartilage stem/progenitor cells in osteoarthritis.Cartilage regeneration for treatment of osteoarthritis: a paradigm for nonsurgical intervention.Mesenchymal Stem/Progenitor Cells Derived from Articular Cartilage, Synovial Membrane and Synovial Fluid for Cartilage Regeneration: Current Status and Future Perspectives.A new strategy to tackle severe knee osteoarthritis: Combination of intra-articular and intraosseous injections of Platelet Rich Plasma.The influence of tissue microenvironment on stem cell-based cartilage repairDCC is expressed in a CD166-positive subpopulation of chondrocytes in human osteoarthritic cartilage and modulates CRE activity.Effects of Platelet-Rich Plasma & Platelet-Rich Fibrin with and without Stromal Cell-Derived Factor-1 on Repairing Full-Thickness Cartilage Defects in Knees of Rabbits.Progenitor Cells from Cartilage: Grade Specific Differences in Stem Cell Marker Expression.Modulation of Synovial Fluid-Derived Mesenchymal Stem Cells by Intra-Articular and Intraosseous Platelet Rich Plasma AdministrationEvidence of a Viable Pool of Stem Cells within Human Osteoarthritic Cartilage.Characterisation of a divergent progenitor cell sub-populations in human osteoarthritic cartilage: the role of telomere erosion and replicative senescence.Combination of Intra-Articular and Intraosseous Injections of Platelet Rich Plasma for Severe Knee Osteoarthritis: A Pilot Study.Early changes in the knee of healer and non-healer mice following non-invasive mechanical injury.Chondrosarcoma: A Rare Misfortune in Aging Human Cartilage? The Role of Stem and Progenitor Cells in Proliferation, Malignant Degeneration and Therapeutic Resistance.Reserve or Resident Progenitors in Cartilage? Comparative Analysis of Chondrocytes versus Chondroprogenitors and Their Role in Cartilage Repair.Evaluation and comparison of the in vitro characteristics and chondrogenic capacity of four adult stem/progenitor cells for cartilage cell-based repair.Regenerative medicine in rheumatic disease-progress in tissue engineering.Contribution of the Interleukin-6/STAT-3 Signaling Pathway to Chondrogenic Differentiation of Human Mesenchymal Stem Cells.
P2860
Q26852836-20585567-DF3B-4654-AC1E-9168558B5D7BQ28081958-BDFC0D1C-1820-4B4F-95D7-4ED469338F7EQ30539223-9828AF59-55BF-44B1-B6F9-038BFD1C313DQ33765924-5040D2CC-602D-4616-9425-7B8B1246FEA7Q33872729-3FB38497-58DE-4064-AB7C-2DD186CEE78EQ33972697-CCA80280-C7EB-4605-9412-D44E1488B189Q34103614-8E0701B3-A333-44A6-B202-6FD60FA2FF9FQ35048455-F2D7B713-AEA2-491D-ACB1-01CBFC1556FAQ35572341-47E35527-950F-4985-BB02-8C4BAA2CD2BAQ35619228-1AB20C25-35CF-45A0-9419-6D4B880A1D77Q35658985-CC602DFE-CDC4-46A7-83D2-4CBB10296652Q35783681-F3D137AE-C5B5-4626-A5BC-91BB1C552769Q36084922-C941220F-CDB2-4320-96C5-796B8F4E905AQ36495041-826B614A-DCF5-435F-8461-BF0EDEE5838FQ36841131-DE3B23AB-5A0E-4992-9DBE-35F53B6C4E15Q36930489-0A6B3D36-33FB-416E-A95F-5904D20F4703Q37342604-C53E8E3D-DF27-4D78-8F86-73C9D3FA376AQ37365265-E4FBC253-D895-4216-A228-C775AB91E993Q37516178-4F8C7AB1-A6BE-49C9-B350-E88511D453AAQ38072064-C2D08C10-46FB-4F6E-888E-D32B09ABC8BCQ38202880-39D7AB41-5229-4024-906A-784E8B9E0924Q38253187-FD9A9923-6329-482B-B0C7-F5B29C714E9FQ38299141-D08B82A3-0F8F-4E8A-BFD0-85FA91549DE0Q38510159-634FC6CB-EFEB-4212-837A-ECF4E82B0C3BQ38655477-95927F26-AAFB-4B9D-BFDC-6E7AD57E8D51Q38756291-4B71FEAC-EA96-48A5-81A8-36D00960110CQ38910223-9DEA3E21-1B8B-4F24-B7D0-9AF11E1D9126Q38981150-A90560A4-A58C-4AB7-8587-5FE6741E0C09Q39182129-DB78945F-037B-47B0-AB61-ED5BDAC74D36Q41574177-5A558035-C95A-488F-965D-6CAE08C40A66Q41581094-EC928111-0E08-490A-B794-BFD3AA59C91EQ41907916-9C4BBE14-F154-4C99-A82F-B6138617258FQ42227385-CFE29B2B-1983-4504-BAB1-5987795738D4Q42416356-9C96C136-967A-4FB7-883F-7B0102AF1941Q47145235-0011DB9E-DF92-4B5F-904E-E4992CC1B295Q48182725-DF4E8FE6-F718-4EC3-95C3-3983FC91A073Q50092357-0F2EB582-5342-4198-9ED3-98B04A6C9B25Q50919367-33F6EA51-40B9-47BE-8A23-84A3C67C3D31Q51578843-7C0F0C99-E1DD-4EC5-A253-BDC763FE31F5Q53633328-92F1FFF1-FCDD-4691-9734-290C5E100958
P2860
Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilage.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Relative percentage and zonal ...... rthritic and normal cartilage.
@ast
Relative percentage and zonal ...... rthritic and normal cartilage.
@en
type
label
Relative percentage and zonal ...... rthritic and normal cartilage.
@ast
Relative percentage and zonal ...... rthritic and normal cartilage.
@en
prefLabel
Relative percentage and zonal ...... rthritic and normal cartilage.
@ast
Relative percentage and zonal ...... rthritic and normal cartilage.
@en
P2093
P2860
P356
P1476
Relative percentage and zonal ...... rthritic and normal cartilage.
@en
P2093
Christian Kaps
David Pretzel
Michaela Endres
Raimund W Kinne
Saifeddin Alsalameh
Stefanie Linss
Steffen Rochler
P2860
P2888
P356
10.1186/AR3320
P577
2011-04-15T00:00:00Z
P5875
P6179
1049103657